Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-07-06 10:59 am Purchase | 2021-07-02 | 13G | Tempest Therapeutics, Inc. TPST | FMR LLC | 49,838 9.764% | 49,838 (New Position) | Filing History |
| 2021-04-13 10:06 am Unchanged | 2021-03-29 | 13D | Millendo Therapeutics, Inc. MLND | New Enterprise Associates 15 L.P. | 117,760 9.300% | 0 (Unchanged) | Filing History |
| 2021-04-07 5:25 pm Purchase | 2021-03-18 | 13G | Millendo Therapeutics, Inc. MLND | Ikarian Capital, LLC | 89,868 7.100% | 89,868 (New Position) | Filing History |
| 2021-03-15 7:54 pm Purchase | 2021-03-03 | 13G | Millendo Therapeutics, Inc. MLND | Citadel Advisors LLC | 61,777 4.900% | 61,777 (New Position) | Filing History |
| 2021-02-16 4:13 pm Sale | 2020-12-31 | 13G | Millendo Therapeutics, Inc. MLND | Great Point Partners, LLC | 18,000 1.420% | -97,317 (-84.39%) | Filing History |
| 2021-02-16 07:02 am Unchanged | 2020-12-31 | 13G | Millendo Therapeutics, Inc. MLND | Roche Finance Ltd | 72,612 5.700% | 0 (Unchanged) | Filing History |